Terms: = Sarcomas AND JAK2, ENSG00000096968, O60674, JTK10, 3717 AND Treatment
30 results:
1. Resveratrol Loaded by Folate-Modified Liposomes Inhibits Osteosarcoma Growth and Lung Metastasis via Regulating jak2/STAT3 Pathway.
Zhu WT; Zeng XF; Yang H; Jia ML; Zhang W; Liu W; Liu SY
Int J Nanomedicine; 2023; 18():2677-2691. PubMed ID: 37228445
[TBL] [Abstract] [Full Text] [Related]
2. De novo myeloid sarcoma mimicking gynecological tumors: a retrospective case series of eight patients.
Gu Y; Zheng H; Mo S; Guo T; Chen L; Yang J; Xiang Y
BMC Womens Health; 2023 Mar; 23(1):141. PubMed ID: 36978050
[TBL] [Abstract] [Full Text] [Related]
3. FANCD2 inhibits ferroptosis by regulating the jak2/STAT3 pathway in osteosarcoma.
Li X; Liu J
BMC Cancer; 2023 Feb; 23(1):179. PubMed ID: 36814203
[TBL] [Abstract] [Full Text] [Related]
4. Telocinobufagin inhibits osteosarcoma growth and metastasis by inhibiting the jak2/STAT3 signaling pathway.
Ma X; Xu W; Jin X; Mu H; Wang Z; Hua Y; Cai Z; Zhang T
Eur J Pharmacol; 2023 Mar; 942():175529. PubMed ID: 36690054
[TBL] [Abstract] [Full Text] [Related]
5. Curculigoside Represses the Proliferation and Metastasis of Osteosarcoma via the JAK/STAT and NF-κB Signaling Pathways.
Guo H; Zheng L; Guo Y; Han L; Yu J; Lai F
Biol Pharm Bull; 2022; 45(10):1466-1475. PubMed ID: 36184504
[TBL] [Abstract] [Full Text] [Related]
6. Quercetin encapsulated in folic acid-modified liposomes is therapeutic against osteosarcoma by non-covalent binding to the JH2 domain of jak2 Via the jak2-STAT3-PDL1.
Jing D; Wu W; Chen X; Xiao H; Zhang Z; Chen F; Zhang Z; Liu J; Shao Z; Pu F
Pharmacol Res; 2022 Aug; 182():106287. PubMed ID: 35671921
[TBL] [Abstract] [Full Text] [Related]
7. Asiatic Acid Induces Mitochondrial Apoptosis via Inhibition of jak2/STAT3 Signalling Pathway in Human Osteosarcoma.
Yan BF; Chen X; Liu J; Liu SJ; Zhang JZ; Zeng QQ; Duan JA
Folia Biol (Praha); 2021; 67(3):108-117. PubMed ID: 35151244
[TBL] [Abstract] [Full Text] [Related]
8. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the jak2/STAT3 Signaling Pathway.
Jia F; Liu Y; Dou X; Du C; Mao T; Liu X
Oxid Med Cell Longev; 2022; 2022():8245614. PubMed ID: 35116094
[TBL] [Abstract] [Full Text] [Related]
9. FAT10 stimulates the development of osteosarcoma by regulating the JAK/STAT signaling pathway.
Shi F; Li L; Cheng Y
J BUON; 2021; 26(5):2090-2096. PubMed ID: 34761621
[TBL] [Abstract] [Full Text] [Related]
10. Curcumin Analogue L48H37 Suppresses Human Osteosarcoma U2OS and MG-63 Cells' Migration and Invasion in Culture by Inhibition of uPA via the JAK/STAT Signaling Pathway.
Lu KH; Wu HH; Lin RC; Lin YC; Lu PW; Yang SF; Yang JS
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374783
[TBL] [Abstract] [Full Text] [Related]
11. [High Expression Level of SP1, CSF1R, and PAK1 Correlates with Sensitivity of Leukemia Cells to the Antibiotic Mithramycin].
Vagapova ER; Lebedev TD; Tikhonova AD; Goikhman BV; Ivanenko KA; Spirin PV; Prassolov VS
Mol Biol (Mosk); 2020; 54(3):522-528. PubMed ID: 32492016
[TBL] [Abstract] [Full Text] [Related]
12. ML264 inhibits osteosarcoma growth and metastasis via inhibition of jak2/STAT3 and WNT/β-catenin signalling pathways.
Huang H; Han Y; Chen Z; Pan X; Yuan P; Zhao X; Zhu H; Wang J; Sun X; Shi P
J Cell Mol Med; 2020 May; 24(10):5652-5664. PubMed ID: 32285603
[TBL] [Abstract] [Full Text] [Related]
13. Investigation on the Genomic Characterization of Uterine Sarcoma for rAd-
Xia Y; Wang L; Ma X; Li X
Hum Gene Ther; 2020 Aug; 31(15-16):881-890. PubMed ID: 32013587
[TBL] [Abstract] [Full Text] [Related]
14. Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study.
Zhang C; Guo X; Xu Y; Han X; Cai J; Wang X; Wang G
Sao Paulo Med J; 2019; 137(5):423-429. PubMed ID: 31939567
[TBL] [Abstract] [Full Text] [Related]
15. Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A.
Wang Z; Wang C; Zuo D; Zhang T; Yin F; Zhou Z; Wang H; Xu J; Mao M; Wang G; Hua Y; Sun W; Cai Z
Int J Biol Sci; 2019; 15(3):668-679. PubMed ID: 30745853
[TBL] [Abstract] [Full Text] [Related]
16. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
[TBL] [Abstract] [Full Text] [Related]
17. Clinicopathological characteristics of de novo and secondary myeloid sarcoma: A monocentric retrospective study.
Claerhout H; Van Aelst S; Melis C; Tousseyn T; Gheysens O; Vandenberghe P; Dierickx D; Boeckx N
Eur J Haematol; 2018 Jun; 100(6):603-612. PubMed ID: 29532520
[TBL] [Abstract] [Full Text] [Related]
18. Catalpol suppresses osteosarcoma cell proliferation through blocking epithelial-mesenchymal transition (EMT) and inducing apoptosis.
Wang L; Xue GB
Biochem Biophys Res Commun; 2018 Jan; 495(1):27-34. PubMed ID: 29032182
[TBL] [Abstract] [Full Text] [Related]
19. Clinical characteristics, molecular profile and outcomes of myeloid sarcoma: a single institution experience over 13 years.
Kaur V; Swami A; Alapat D; Abdallah AO; Motwani P; Hutchins LF; Jethava Y
Hematology; 2018 Jan; 23(1):17-24. PubMed ID: 28574302
[TBL] [Abstract] [Full Text] [Related]
20. Memantine inhibits degradation of the articular cartilage extracellular matrix induced by advanced glycation end products (AGEs).
Zhao J; Yu Y; Wu Z; Wang L; Li W
Biomed Pharmacother; 2017 Jul; 91():1193-1198. PubMed ID: 28545202
[TBL] [Abstract] [Full Text] [Related]
[Next]
